Jupiter Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $17.7M | Buy |
+28,368
| New | +$17.7M | 0.28% | 98 |
|
|
2019
Q4 | – | Sell |
-44,604
| Closed | -$12.4M | – | 497 |
|
|
2019
Q3 | $12.4M | Sell |
44,604
-56,345
| -56% | -$15.6M | 0.16% | 152 |
|
|
2019
Q2 | $31.6M | Sell |
100,949
-42,596
| -30% | -$13.3M | 0.32% | 92 |
|
|
2019
Q1 | $58.9M | Buy |
143,545
+69,810
| +95% | +$28.7M | 0.54% | 60 |
|
|
2018
Q4 | $27.5M | Buy |
73,735
+34,314
| +87% | +$12.8M | 0.24% | 102 |
|
|
2018
Q3 | $15.9M | Sell |
39,421
-52,546
| -57% | -$21.2M | 0.11% | 138 |
|
|
2018
Q2 | $31.7M | Sell |
91,967
-548,856
| -86% | -$189M | 0.23% | 103 |
|
|
2018
Q1 | $221M | Buy |
640,823
+391,788
| +157% | +$135M | 1.76% | 15 |
|
|
2017
Q4 | $93.6M | Sell |
249,035
-76,320
| -23% | -$28.7M | 0.86% | 42 |
|
|
2017
Q3 | $145M | Buy |
325,355
+325,290
| +500,446% | +$145M | 1.52% | 20 |
|
|
2017
Q2 | $31K | Sell |
65
-93,938
| -100% | -$44.8M | ﹤0.01% | 376 |
|
|
2017
Q1 | $36.4M | Buy |
94,003
+77,801
| +480% | +$30.1M | 0.51% | 64 |
|
|
2016
Q4 | $5.95M | Sell |
16,202
-248,199
| -94% | -$91.1M | 0.1% | 139 |
|
|
2016
Q3 | $106M | Buy |
264,401
+153,203
| +138% | +$61.6M | 1.84% | 14 |
|
|
2016
Q2 | $38.8M | Sell |
111,198
-3,875
| -3% | -$1.35M | 0.73% | 43 |
|
|
2016
Q1 | $41.5M | Buy |
115,073
+67,300
| +141% | +$24.3M | 0.85% | 29 |
|
|
2015
Q4 | $25.9M | Buy |
47,773
+32,239
| +208% | +$17.5M | 0.69% | 50 |
|
|
2015
Q3 | $7.23M | Buy |
15,534
+5,487
| +55% | +$2.55M | 0.2% | 116 |
|
|
2015
Q2 | $5.13M | Buy |
10,047
+9,653
| +2,450% | +$4.92M | 0.15% | 103 |
|
|
2015
Q1 | $177K | Buy |
+394
| New | +$177K | 0.01% | 294 |
|
|
2014
Q1 | – | Sell |
-14,697
| Closed | -$4.05M | – | 401 |
|
|
2013
Q4 | $4.05M | Buy |
+14,697
| New | +$4.05M | 0.34% | 94 |
|